BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 26824706)

  • 41. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
    Kolberg M; Høland M; Agesen TH; Brekke HR; Liestøl K; Hall KS; Mertens F; Picci P; Smeland S; Lothe RA
    Neuro Oncol; 2013 Feb; 15(2):135-47. PubMed ID: 23161774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.
    Carli M; Ferrari A; Mattke A; Zanetti I; Casanova M; Bisogno G; Cecchetto G; Alaggio R; De Sio L; Koscielniak E; Sotti G; Treuner J
    J Clin Oncol; 2005 Nov; 23(33):8422-30. PubMed ID: 16293873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Malignant peripheral nerve sheath tumours in neurofibromatosis 1.
    Evans DG; Baser ME; McGaughran J; Sharif S; Howard E; Moran A
    J Med Genet; 2002 May; 39(5):311-4. PubMed ID: 12011145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FNAC diagnosis of MPNST--a case report.
    Yadavrao KA; Vijaykumar WJ; Kanthirav KG
    Indian J Pathol Microbiol; 2005 Jul; 48(3):383-5. PubMed ID: 16761762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
    Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
    Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma.
    Greto D; Saieva C; Loi M; Desideri I; Delli Paoli C; Lo Russo M; Pezzulla D; Teriaca MA; Lucidi S; Visani L; Terziani F; Olmetto E; Becherini C; Bonomo P; Francolini G; Campanacci DA; Scoccianti G; Livi L
    Am J Clin Oncol; 2019 Oct; 42(10):749-754. PubMed ID: 31503061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multimodal Therapy of Recurrent Malignant Schwannoma].
    Kalita O; Cwiertka K; Vrána D; Vaverka M; Tučková L; Megová M
    Klin Onkol; 2016; 29(5):364-368. PubMed ID: 27739316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
    Friedrich RE; Beer C; Glatzel M; Hagel C
    Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes.
    Shurell E; Singh AS; Crompton JG; Jensen S; Li Y; Dry S; Nelson S; Chmielowski B; Bernthal N; Federman N; Tumeh P; Eilber FC
    Oncotarget; 2016 Sep; 7(39):64300-64308. PubMed ID: 27588404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
    Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
    J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Forearm soft tissue sarcoma: tumors characteristics and oncologic outcomes following limb salvage surgery.
    Baroudi MR; Ferguson PC; Wunder JS; Isler MH; Mottard S; Werier JA; Turcotte RE
    J Surg Oncol; 2014 Nov; 110(6):676-81. PubMed ID: 24910319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
    Trovik CS;
    Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.
    Danielsen SA; Lind GE; Kolberg M; Høland M; Bjerkehagen B; Sundby Hall K; van den Berg E; Mertens F; Smeland S; Picci P; Lothe RA
    Neuro Oncol; 2015 Jan; 17(1):63-9. PubMed ID: 25038505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model.
    Willeumier JJ; Rueten-Budde AJ; Jeys LM; Laitinen M; Pollock R; Aston W; Dijkstra PD; Ferguson PC; Griffin AM; Wunder JS; Fiocco M; van de Sande MA
    BMJ Open; 2017 Feb; 7(2):e012930. PubMed ID: 28196946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of malignant peripheral nerve sheath tumors in pediatric NF1 disease.
    Martin E; Flucke UE; Coert JH; van Noesel MM
    Childs Nerv Syst; 2020 Oct; 36(10):2453-2462. PubMed ID: 32494969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
    Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
    Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.
    Guillamo JS; Créange A; Kalifa C; Grill J; Rodriguez D; Doz F; Barbarot S; Zerah M; Sanson M; Bastuji-Garin S; Wolkenstein P;
    Brain; 2003 Jan; 126(Pt 1):152-60. PubMed ID: 12477702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
    Landry JP; Schertz KL; Chiang YJ; Bhalla AD; Yi M; Keung EZ; Scally CP; Feig BW; Hunt KK; Roland CL; Guadagnolo A; Bishop AJ; Lazar AJ; Slopis JM; McCutcheon IE; Torres KE
    JAMA Netw Open; 2021 Mar; 4(3):e210945. PubMed ID: 33734413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can a less radical surgery using photodynamic therapy with acridine orange be equal to a wide-margin resection?
    Matsubara T; Kusuzaki K; Matsumine A; Nakamura T; Sudo A
    Clin Orthop Relat Res; 2013 Mar; 471(3):792-802. PubMed ID: 23008027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.